Rossari Biotech Limited

Rossari Biotech Limited (ROSSARI) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

rossari.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹476.20
Market cap
2,636 Cr
Stock P/E
18.0
P/B
1.98
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales483 Cr464 Cr473 Cr490 Cr498 Cr513 Cr580 Cr544 Cr586 Cr582 Cr685 Cr697 Cr
Operating expenses (approx.)420 Cr400 Cr409 Cr425 Cr432 Cr448 Cr510 Cr476 Cr514 Cr513 Cr608 Cr617 Cr
EBITDA64 Cr64 Cr64 Cr65 Cr66 Cr65 Cr69 Cr68 Cr72 Cr69 Cr77 Cr81 Cr
OPM %13.1%13.7%13.5%13.3%13.2%12.6%12.0%12.5%12.3%11.8%11.3%11.6%
Other income1 Cr4 Cr0.39 Cr0.95 Cr0.72 Cr0.55 Cr2 Cr1 Cr2 Cr0.51 Cr19 Cr3 Cr
Interest5 Cr4 Cr3 Cr4 Cr4 Cr5 Cr6 Cr6 Cr6 Cr8 Cr9 Cr11 Cr
Depreciation15 Cr15 Cr16 Cr15 Cr15 Cr18 Cr18 Cr18 Cr18 Cr20 Cr24 Cr26 Cr
Profit before tax45 Cr48 Cr46 Cr47 Cr48 Cr42 Cr48 Cr46 Cr50 Cr43 Cr64 Cr48 Cr
Tax %26.5%28.0%25.1%25.7%26.6%25.2%27.8%27.1%25.8%22.9%28.4%26.4%
Net profit33 Cr34 Cr34 Cr35 Cr35 Cr32 Cr34 Cr34 Cr37 Cr33 Cr46 Cr35 Cr
EPS (₹)₹5.97₹6.23₹6.18₹6.32₹6.39₹5.73₹6.22₹6.07₹6.66₹5.92₹8.30₹6.34

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales709 Cr1,483 Cr1,656 Cr1,831 Cr2,080 Cr2,396 CrSign in for TTM
Operating expenses (approx.)586 Cr1,300 Cr1,433 Cr1,581 Cr1,815 Cr2,110 CrSign in for TTM
EBITDA123 Cr183 Cr223 Cr250 Cr265 Cr286 CrSign in for TTM
OPM %17.3%12.4%13.5%13.6%12.7%11.9%Sign in for TTM
Other income9 Cr12 Cr5 Cr7 Cr4 Cr22 CrSign in for TTM
Interest3 Cr13 Cr22 Cr19 Cr18 Cr29 CrSign in for TTM
Depreciation23 Cr48 Cr63 Cr60 Cr67 Cr79 CrSign in for TTM
Profit before tax107 Cr136 Cr144 Cr178 Cr185 Cr203 CrSign in for TTM
Tax %25.1%28.3%25.6%26.4%26.4%26.3%Sign in for TTM
Net profit80 Cr98 Cr107 Cr131 Cr136 Cr149 CrSign in for TTM
EPS (₹)₹15.56₹17.81₹19.46₹23.67₹24.66₹26.95Sign in for TTM
Dividend payout %—2.8%2.6%2.1%2.0%1.9%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital10 Cr11 Cr11 Cr11 Cr11 Cr11 Cr
Reserves398 Cr794 Cr904 Cr1,037 Cr1,174 Cr1,322 Cr
Borrowings—8 Cr74 Cr106 Cr188 Cr408 Cr
Other liabilities153 Cr443 Cr378 Cr419 Cr523 Cr547 Cr
Total liabilities561 Cr1,257 Cr1,368 Cr1,572 Cr1,896 Cr2,289 Cr
Fixed assets (net)168 Cr347 Cr314 Cr315 Cr354 Cr561 Cr
CWIP0.32 Cr1 Cr13 Cr47 Cr140 Cr173 Cr
Investments0 Cr36 Cr51 Cr63 Cr84 Cr62 Cr
Loans & advances1 Cr1 Cr0.29 Cr0.70 Cr1 Cr1 Cr
Inventories95 Cr190 Cr188 Cr282 Cr355 Cr405 Cr
Trade receivables144 Cr305 Cr354 Cr425 Cr475 Cr557 Cr
Cash & bank15 Cr37 Cr70 Cr25 Cr44 Cr75 Cr
Other assets137 Cr339 Cr377 Cr414 Cr444 Cr454 Cr
Total assets561 Cr1,257 Cr1,368 Cr1,572 Cr1,896 Cr2,289 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—29 Cr152 Cr43 Cr137 Cr65 Cr
Cash from investing—-299 Cr-181 Cr-103 Cr-184 Cr-219 Cr
Cash from financing—292 Cr61 Cr16 Cr65 Cr186 Cr
Net cash flow—22 Cr32 Cr-44 Cr19 Cr31 Cr
Free cash flow (OCF − Capex)—-9 Cr120 Cr-88 Cr-21 Cr-200 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %26.9%18.3%16.8%17.1%14.8%13.3%
ROE %21.7%12.9%11.7%12.5%11.5%11.2%
Debtor days747578858385
Inventory days807164849992
Days payable1107062658073
Cash conversion cycle447679104102103
Debt / equity—0.010.080.100.160.31
Current ratio2.362.072.081.991.941.57
Net debt / EBITDA0.000.000.020.320.541.16

Compare with peers

Loading peers…